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Abstract
The lipid lamellae in the stratum corneum (SC) play a key role in the barrier function of the skin. The major lipids are
ceramides (CER), cholesterol (CHOL) and free fatty acids (FFA). In pig SC at least six subclasses of ceramides (referred to as
CER 1, 2^6) are present. Recently it was shown that in mixtures of isolated pig SC ceramides (referred to as CER(1^6)) and
CHOL two lamellar phases are formed, which mimic SC lipid organisation very closely [J.A. Bouwstra et al., 1996, J. Lipid
Res. 37, 999^1011] [1]. Since the CER composition in SC originating from different sources/donors often varies, information
on the effect of variations in CER composition on the SC lipid organisation is important. The results of the present study
with mixtures of CHOL including two different CER mixtures that lack CER 6 (CER(1^5) mixtures) revealed that at an
equimolar molar ratio their lipid organisation was similar to that of the equimolar CHOL:CER(1^6) and CHOL:CER(1,2)
mixtures, described previously. These observations suggest that at an equimolar CHOL:CER ratio the lipid organisation is
remarkably insensitive toward a change in the CER composition. Similar observations have been made with equimolar
CHOL:CER:FFA mixtures. The situation is different when the CHOL:CER molar ratio varies. While in the
CHOL:CER(1^6) mixture the lamellar organisation hardly changed with varying molar ratio from 0.4 to 2, the lamellar
organisation in the CHOL:CER(1^5) mixtures appeared to be more sensitive to a change in the relative CHOL content,
especially concerning the changes in the periodicities of the lamellar phases. In summary, these findings clearly indicate that
at an equimolar CHOL:CER molar ratio the lamellar organisation is least sensitive to a variation in CER composition, while
at a reduced CHOL:CER molar ratio the CER composition plays a more prominent role in the lamellar phases. This
observation may have an implication for the in vivo situation when both the CER composition and the CHOL:CER molar
ratio change simultaneously. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The mammalian skin is a multilayered tissue that
is designed to protect the body against undesired
in£uences from the external environment. The main
barrier, which is located in the upper layer of the
skin, the stratum corneum (SC) [2], is the major
problem for transdermal and dermal delivery of
drugs. The SC consists of dead cells enclosed by
hydrophobic crystalline lipid lamellar regions. Since
the lipids form the only continuous region in the SC
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and consequently the di¡using substances always
have to pass these lipid regions, the lipid organisa-
tion is considered to be very important for the skin
barrier function [3^5].
In previous studies it was found that the lipids are
mainly organised in lipid lamellae oriented approxi-
mately parallel to the corneocyte surface [6^8]. Fur-
thermore X-ray di¡raction and NMR studies re-
vealed that the lateral packing of SC lipids is
mainly crystalline or hexagonal [9^14]. Two lamellar
phases could be identi¢ed with repeat distances of
approximately 6 (referred to as the short periodicity
phase) and 13 nm (referred to as the long periodicity
phase) [10,11,13,14]. Only the latter is present in the
skin of all examined species. In contrast to the 6 nm
lamellar phase the lipid organisation of the 13 nm
lamellar phase is very unusual [15,16]. Both the pres-
ence of the 13 nm phase in all species examined and
its exceptional lipid organisation are indicative of the
importance of this phase for a competent skin barrier
function.
The main lipid classes in SC are free fatty acids
(FFA), cholesterol (CHOL) and ceramides (CER).
SC ceramides consist of at least six ceramides
(CER(1^6)) that di¡er from each other by the head
group architecture and by the mean fatty acid chain
length. The fatty acid esteri¢ed to the amide of the
(phyto)sphingosine head group can be either K-hy-
droxy or non-hydroxy fatty acid [17]. In pig SC the
fatty acid chain length varies between 16 (CER 5)
and 33 C atoms (CER 1), in which the fatty acids
of C24 and C26 chain lengths are most abundantly
present.
Information on the relationship between lipid or-
ganisation and composition is of great importance to
unravel the mechanism controlling the skin barrier
function. This is particularly demonstrated in dis-
eased skin, in which an impaired barrier function
can often be ascribed to an altered lipid composition
and organisation. However, until now only limited
information is available about the relation between
SC lipid composition and organisation.
The research with native SC on the role of indi-
vidual lipids on the SC lipid organisation is ham-
pered by the complexity of the native tissue, in which
next to lipid lamellae also corneocytes and various
protein structures, like desmosomes, are present. In
addition, no systematic modulation of SC lipid com-
position can be achieved with the native tissue. Such
studies, however, can be performed with mixtures
prepared from isolated SC lipids. Our recent studies
with mixtures prepared from CHOL and isolated SC
ceramides (CER(1^6)) [1,18] revealed that these lipid
mixtures mimic the lipid organisation of intact SC
closely. Namely, over a wide CHOL:CER(1^6) mo-
lar ratio (ranging from 0.2 to 2) two lamellar phases
were formed with periodicities of 12.2 and 5.2 nm,
respectively. When long-chain FFA were added (with
major fractions being C24 and C26) as present in the
SC, the periodicity of the lamellar phases increased
slightly to 13.1 and 5.3 nm, respectively, mimicking
the SC lipid phase behaviour even more closely. In
contrast, when short chain free fatty acids (with ma-
jor fractions being C16 and C18 that are not present
in the SC) were added to ceramides or ceramides:
cholesterol mixtures phase separation occurred
[19,1,20]. This is most probably due to a mismatch
in chain length between free fatty acids and ceram-
ides.
Additional studies revealed that the fraction of
lipids that forms the long periodicity phase increases
in the presence of CER 1 [16]. Furthermore, the
12 nm lamellar phase was not detected in mixtures
of bovine brain ceramides III and IV being similar in
molecular structure to CER 2 and CER 3 [21^23].
To examine in more detail the role ceramides play
in the SC lipid organisation, in the present study the
e¡ect of CER composition on the SC lipid organisa-
tion has been further assessed with two di¡erent
CER mixtures: CER I(1^5) and CER II(1^5). We
chose mixtures lacking CER 6, since CER 6 was
found to be present in only small amounts in recon-
structed human epidermis exerting a deviation in lip-
id organisation [24]. Compared to CER I(1^5) mix-
ture, the CER II(1^5) mixture contained an increased
relative amount of CER 2 and a decreased amounts
of CER 3 and CER 4, while the relative amounts of
CER 1 and 5 were kept constant. This variation is of
interest based on a recently proposed model for the
12.2 nm lamellar phase. In this molecular model it is
proposed that the role of CER 2, CER 3 and CER 4
in the 12.2 nm lamellar phase is very similar. In
contrast, CER 1 and CER 5 are located at distinct
positions in this phase, which makes the role of CER
1 and CER 5 in the organisation of this phase very
prominent [16]. The lipid organisation of equimolar
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mixtures of CHOL:CER(1^5) and CHOL:CER(1^
5):FFA and of CHOL:CER(1^5) mixtures with a
reduced amount of CHOL has been studied by
X-ray di¡raction technique. Furthermore, the results
of the present and previous studies have been com-
bined to propose a generalised picture illustrating the
e¡ects of variations in CER composition on the SC
lipid organisation.
2. Materials and methods
2.1. Isolation of stratum corneum from pig skin
Fresh pig skin was obtained from a slaughter-
house. First, the apical side of the skin was brie£y
washed with hexane (0.03 ml/cm2) in order to remove
the surface lipids. The SC was separated from the
epidermis as described earlier [1].
2.2. Extraction, separation and identi¢cation of lipids
from stratum corneum
SC lipids extracted using the method of Bligh and
Dyer [25], were stored in chloroform:methanol (2:1,
v/v) at 320‡C under nitrogen until use. Subse-
quently, the extracted lipids were applied on a silica
gel 60 (Merck) column (diameter 2 cm, length 33 cm)
and individual lipid classes were isolated by sequen-
tial elution [1]. The lipid composition of individual
fractions was established by one-dimensional high
performance thin layer chromatography, as described
before [26].
2.3. Ceramide isolation and preparation of lipid
mixtures
Fractions containing individual CER isolated by
column chromatography were mixed for preparation
of two di¡erent ceramide mixtures lacking CER 6:
CER I(1^5) and CER II(1^5). The CER I(1^5) and
CER II(1^5) fractions originated from SC obtained
from the same pig. However, in the CER II(1^5)
mixture an additional amount of CER 2 was added,
while CER 3 and CER 4 were removed as compared
to the CER I(1^5) mixture (Table 1).
The ceramides and cholesterol were mixed in
various molar ratios. For calculation of the mean
ceramide molecular weight being 700, the data on
the ceramide composition and alkyl chain length
distributions [17] were used. Approximately 2 mg
of lipids were solubilised in 80 Wl chloroform/meth-
anol (2:1) at the desired composition and applied on
mica. A detailed description is given elsewhere [1].
The applied lipid mixtures were covered with 1^2
ml acetate bu¡er at pH 5.0 (10 mM) and kept
under nitrogen. A pH 5 was chosen, since that is
the pH of the skin surface [27]. Mixtures were pre-
pared from CHOL, CER(1^5) and FFA. Long-chain
free fatty acids mixed in a molar ratio according to
Wertz et al. [28] were used for preparation of the
FFA mixture. The following fatty acids were in-
cluded in the lipid mixtures: C16:0, C18:0, C22:0,
C24:0 and C26:0 in a molar ratio of 1:3:42:37:7,
respectively.
2.4. X-Ray di¡raction measurements
2.4.1. Small and wide angle X-ray di¡raction
(SAXD)
All measurements were carried out at the Synchro-
tron Radiation Source at Daresbury Laboratory us-
ing station 8.2. This station has been built as a part
of a NWO/SERC agreement. The samples were put
in a specially designed sample holder with two mica
windows [13]. The sample-detector distance was set
to 1.7 m. Calibration of the detector was carried out
with rat tail and cholesterol. From the scattering
angle the scattering vector (Q) was calculated
Q = 4Z(sin a)/V, in which V is the wavelength being
0.154 nm at the sample position. Simultaneously with
the small angle X-ray di¡raction experiments wide
angle X-ray di¡raction measurements were carried
out using an INEL detector. The distance between
the sample and INEL detector was set to approxi-
mately 0.25 m. The INEL detector was calibrated
with cholesterol and SiO2. No absolute intensities
could be calculated. For this reason the intensity of
the tail of the di¡raction curves were normalised.
The di¡raction curves were plotted as a function
of Q. For comparison the curves are staggered and
the intensity is given in arbitrary units. From the
positions of a series of peaks (Qn) the periodicity
of a lamellar phase was calculated using the equation
Qn = 2Zn/d, in which d is the periodicity and nth or-
der of the di¡raction peak.
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3. Results
3.1. Long range ordering
3.1.1. CER I(1^5)
The X-ray di¡raction curves of mixtures prepared
from CER I(1^5) and CHOL at molar ratios of 0.2,
0.4 and 1 are plotted in Fig. 1A,B. The di¡raction
curve of the 0.2 molar mixture revealed one strong
peak at 5.4 (Q = 1.16 nm31) nm and several weaker
di¡raction peaks located at 12.6 (Q = 0.5 nm31), 6.0
(Q = 1.05 nm31), 4.23 (Q = 1.49 nm31), 3.09 (Q = 2.03
nm31), 2.15 (Q = 2.92 nm31), 1.79 (Q = 3.51 nm31),
and 1.55 nm (Q = 4.05 nm31, not shown) (see Table
2). The 12.6 (1st order), 6.0 (2nd order), 4.23 (3rd
order), 3.09 (4th order), 2.15 (6th order) and 1.55
(8th order) peaks are based on a lamellar phase
with a repeat distance of 12.5 nm. The 5.4 (1st order)
nm peak is most probably a ¢rst order peak of the
5.4 nm lamellar phase. Recently both lamellar phases
have been found in mixtures of CER(1^6) and
CHOL [1]. Possibly the 1.79 nm peak is the third
order peak of the 5.4 nm phase (see below), although
it can also be assigned as the 7th order of the 12.5
nm phase. Increasing the CHOL content to a molar
ratio of 0.4 shifted the di¡raction peaks based on the
12.5 nm phase to longer spacings and increased the
intensities of the peaks based on the long periodicity
phase. The di¡raction peaks of this phase are now
located at 12.8 (Q = 0.49 nm31), 6.1 (Q = 1.03 nm31),
4.24 nm (Q = 1.48 nm31) and 2.14 nm (Q = 2.94
nm31, 6th order). The peaks based on the short pe-
riodicity phase were slightly shifted to smaller spac-
ings, being now at 5.25 (Q = 1.20 nm31), 2.65
(Q = 2.37 nm31) and 1.77 (Q = 3.55 nm31) nm. Be-
cause an increase in CHOL content shifts the 1.79
nm peak to a smaller spacing being 1.77 nm, this
peak is most likely based on the short periodicity
phase. Finally two weak peaks at 3.34 nm (Q = 1.88
nm31) and 1.68 nm (Q = 3.76nm31) spacing appeared
which could be identi¢ed as crystalline CHOL that
phase separated. Increasing the CHOL content to a
molar ratio of 1 decreased the intensities of the peaks
based on the long periodicity lamellar phase slightly
and shifted these peaks to a longer spacing being
now 13.1 (Q = 0.48 nm31), 6.4 (Q = 0.98 nm31), 4.4
(Q = 1.42 nm31) and 2.23 (Q = 2.82 nm31) nm. The
intensities of the peaks based on the short periodicity
phase did not change, but were again slightly shifted
to smaller spacings being now 5.1 (Q = 1.23 nm31)
and 2.63 (Q = 2.38 nm31) nm, respectively. Further-
more the intensities of the peaks assigned to crystal-
line CHOL increased with increasing CHOL content,
indicating that the amount of CHOL present in crys-
talline form increased.
In the presence of long-chain FFA in an equimolar
mixture of CHOL, CER I(1^5) and FFA a slight
increase in the repeat distance of the short periodicity
phase was observed, while the repeat distance of the
long periodicity phase did not change upon addition
of FFA (see Table 2). The phase separated CHOL
was still present as indicated by the presence of 3.33
and 1.68 nm re£ections.
3.1.2. CER II(1^5)
The X-ray di¡raction curves of mixtures prepared
from CER II(1^5) and CHOL at molar ratios of 0.2,
0.4 and 1 are depicted in Fig. 1C,D. The di¡raction
curve of the mixture at a 0.2 molar ratio revealed one
strong broad di¡raction peak at 5.8 nm (Q = 1.08
Table 1
Composition of the pig ceramide mixtures used in this study and in previous ones
Ceramides CER I(1^5) CER II(1^5)a CER(1^6) [1] CER(1,2)b [31] CER(2^6)
CER 1 4.7 3.4 7.8 12 ^
CER 2 56.7 73.5 55.4 88 43.2
CER 3 18.5 9.0 17.6 ^ 25.8
CER 4 9.8 5.4 3.6 ^ 5.5
CER 5 10.3 8.6 9.9 ^ 19.3
CER 6 ^ ^ 5.6 ^ 6.3
CER(1^5), CER(1^6) and CER(2^6) are isolated from SC obtained from di¡erent pigs. The composition is given in percentage
weight.
aWeight ratios have been changed by adding CER 2 and removing CER 3 and CER 4.
bRatio chosen such that CER 1:CER 2 weight fraction is similar to that in the CER(1^6) mixture.
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Fig. 1. (A) Small angle X-ray di¡raction curves of mixtures of CHOL and CER I(1^5) in a molar ratio of 0.2:1 and 0.4:1. The num-
bers I, II and III refer to the 1st, 2nd and 3rd order di¡raction peaks of a lamellar phase varying in periodicity between 5.3 and
5.4 nm. The numbers 1, 2, 3, 4 and 6 refers to the orders peak of lamellar phase varying in repeat distance between 12.5 and 12.7 nm.
* denotes cholesterol. For comparative reasons the curves are staggered and the intensity is plotted in arbitrary units. (B) Small angle
X-ray di¡raction curves of a CHOL:CER I(1^5) mixture in a molar ratio of 1:1 and a mixture of CHOL, CER I(1^5) and free fatty
acids (FFA) in a molar ratio of 1:1:1. The numbers I, II and III refer to the 1st, 2nd and 3rd order of the lamellar phase varying in
repeat distance between 5.1 and 5.4 nm, the numbers 1, 2 and 3 refer to the lamellar phase with a repeat distance of approximately
13 nm. * denotes cholesterol. For further explanations see A. (C) Small angle X-ray di¡raction curves of mixtures of CHOL and
CER II(1-5) in a molar ratio of 0.2:1 and 0.4:1. The numbers I, II and III refer to the 1st, 2nd and 3rd order di¡raction peaks of
the phase with a repeat distance varying between 5.6 and 5.7 nm. The numbers 2 and 3 refer to the 2nd and 3rd order peaks of the
lamellar phase with a repeat distance of approximately 13 nm. CHOL denotes cholesterol. For further explanations see A. (D) Small
angle X-ray di¡raction curves of a CHOL:CER II(1^5) mixture in a molar ratio of 1:1 and a mixture of CHOL, CER I(1^5) and
free fatty acids (FFA) in a molar ratio of 1:1:1. The numbers I, II and III refer to the 1st, 2nd and 3rd order of a lamellar phase
varying in repeat distance between 5.3^5.5 nm, the numbers 1, 2 and 3 refer to a lamellar phase with a periodicity of approximately
13 nm. CHOL denotes cholesterol. For further explanations see A.
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nm31) and a shoulder at a spacing of 4.3 nm
(Q = 1.45 nm31). In addition a very weak peak at a
spacing of 1.83 nm (Q = 3.43 nm31) was observed.
The 5.8 and 1.83 nm peaks represent the 5.7 nm
lamellar phase, while the 4.3 nm phase indicates
that a small fraction of lipids formed the long perio-
dicity lamellar phase of approximately 12^13 nm.
Furthermore, a strong scattering at low Q value is
seen with all CER II(1^5) mixtures. This might be
due to a crystallisation of lipid mixtures into small
crystals. The small crystal size also limits the number
of repeating unit cells (N). Since the width at half
maximum of the di¡raction peaks is proportional
to 1/Nd (d is the peak spacing), the broad di¡raction
peaks in the patterns of the CER II(1^5) mixtures
can also be explained by a small crystal size. Increas-
ing the CHOL content to molar ratio of 0.4 shifted
the spacing of the strong peak to 5.6 nm (Q = 1.12
nm31). A new peak appeared at 2.75 nm (Q = 2.28
nm31). The 5.6 and 2.75 nm spacings indicate the
presence of a lamellar phase with a periodicity of
5.6 nm. In addition two shoulders were observed at
4.4 and approximately 6.2 nm spacing indicating the
presence of the approximately 13 nm long periodicity
phase. Finally, a very weak di¡raction peak was ob-
served at a 3.33 nm spacing indicating that CHOL
starts to phase separate at a molar ratio of 0.4. In-
creasing the CHOL content further to a molar ratio
of 1.0 revealed the presence of two lamellar phases
with periodicities of 5.3 and approximately 13 nm,
respectively. The 5.3 nm phase is based on the dif-
fraction peaks at 5.3 (Q = 1.18 nm31), 2.65 (Q = 2.39
Table 3
Variation in CER composition in human SC
Vicanova (SC) [32] Vicanova (E) [33] Ponec (E) [34] Schreiner (SC) [30]
CER 1 6.6 9.7 10.2 5.0 9.5 12.3 12.4
CER 2 22.7 20.8 22.1 18.8 18.8 17.7 16.2
CER 3 20.2 20.2 21.9 23.5 15.3 16.4 18.2
CER 4 6.0 7.1 6.9 3.9 7.3 10.2 8.3
CER 5 21.5 19.8 16.7 23.4 20.8 19.7 20.2
CER 6 7.5 6.7 7.5 10.1 8.9 8.0 8.9
CER 7 14.7 15.5 14.7 14.1 19.1 15.8 15.5
All values are given in weight percentages. E indicates CER isolated from epidermis. SC indicates CER isolated from stratum
corneum.
Table 2
The long range ordering of the CHOL:CER(1^5) and CHOL:CER(1^5):FFA mixtures
Composition Long periodicity phase Short periodicity phase CHOL
CHOL:CER I(1^5)
0.2:1 12.5 : 12.6 (1), 6.0 (2), 4.23 (3), 3.09 (4),
2.15 (6), 1.55 (8)
5.4 : 5.4 (1), 1.79 (3) ^
0.4:1 12.7 : 12.8 (1), 6.1 (2), 4.24 (3), 2.14 (6) 5.3 : 5.25 (1), 2.65 (2), 1.77 (3) 3.34, 1.68
1:1 13.0 : 13.1 (1), 6.4 (2), 4.4 (3), 2.23 (6) 5.1 : 5.1 (1), 2.63 (2) 3.34, 1.68
CHOL:CER I(1^5):FFA
1:1:1 13.1 : 13.1 (1), 6.3 (2), 4.45 (3), 2.25 (6) 5.4 : 5.4 (1), 2.72 (2), 1.83 (3) 3.33, 1.68
CHOL:CER II(1^5)
0.2:1 13a : 4.3 (3) 5.7 : 5.8 (1), 1.83 (3) ^
0.4:1 13a : 6.2 (2), 4.4 (3) 5.6 : 5.6 (1), 2.75 (2) 3.33
1:1 13a :6.1 (1), 4.27 (2), 2.13 (6) 5.3 : 5.3 (1), 2.65 (2), 1.77 (3) 3.33, 1.68
CHOL:CER II(1^5):FFA
1:1:1 13a : 6.2 (2), 4.4 (3) 5.5 : 5.5 (1), 2.73 (2), 1.83 (3) 3.33, 1.68
The spacings of the di¡raction peaks and the periodicity of the lamellar phases are presented in nm. The data are given as follows.
The periodicities are given in bold and the spacings are given italics. CHOL is indicated by two re£ections of the triclinic lattice.
aThe periodicity of the 13 nm phase is less accurate due to the broad re£ections.
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nm31) and 1.77 (Q = 3.54 nm31) nm, while the 13 nm
phase is based on the di¡raction peaks at
6.1(Q = 1.03 nm31 ), 4.27 (Q = 1.59 nm31) and 2.13
(Q = 2.94 nm31) nm spacing. The ¢rst order di¡rac-
tion peak of the long periodicity phase was not ob-
served with any mixture prepared from CHOL and
CER II(1^5). In addition, two re£ection located at
3.33 and 1.68 nm were observed. These re£ections
can be attributed to the presence of crystalline
CHOL.
The addition of FFA resulting in an equimolar
mixture of CHOL, CER II(1^5) and FFA revealed
a di¡raction curve similar to that of the equimolar
mixture prepared from CER I(1^5) and CHOL. Only
the repeat distance of the short periodicity phase in-
creased slightly to 5.5 nm (see Table 2). The re£ec-
tions attributed to phase separated CHOL were still
present.
3.2. Short range ordering
In this study small sample sizes were used contain-
ing mostly typically 1^2 mg of lipids. This resulted in
a low signal/noise ratio in the wide angle patterns,
which caused the halos at Q = 8.8 nm31 and Q = 14
nm31 (Fig. 2, only curve a).
3.2.1. CER I(1^5)
The di¡raction curve of CHOL:CER I(1^5) mix-
tures prepared at molar ratios of 0.2, 0.4 and 1.0
revealed one broad peak at 0.416 nm (Fig. 2), which
is characteristic for a hexagonal lateral packing. At
increased CHOL content no change in spacing was
observed. However at molar ratios of 0.4 and 1.0 two
additional re£ections were present at approximately
0.59 and 0.386 nm indicating that CHOL phase sep-
arates at higher CHOL:CER(1^5) molar ratios. The
broad re£ection at 0.45 nm in Fig. 2 (curves b, c and
d) increases in intensity with increasing CHOL con-
tent. This is most likely due to the presence of a
number of re£ections located between 0.45 (Q = 14
nm31) and 0.56 (Q = 11.2 nm31) that can be attrib-
uted to crystalline CHOL. Due to the limited reso-
lution of the wide angle wire detector, these CHOL
peaks could not be detected separately. The presence
of crystalline CHOL is in agreement with observa-
tions made with SAXD (Fig. 1A).
The di¡raction curve of a mixture prepared from
CHOL, CER(1^5) and long-chain FFA at an equi-
molar ratio is plotted in Fig. 2 (curve d). The dif-
fraction pattern revealed re£ections at 0.417 and
0.378 nm indicating an orthorhombic lateral packing.
Since the 0.416 nm re£ection of the hexagonal lateral
sublattice is located at the same position as one of
the re£ections attributed to the orthorhombic phase,
the presence of a hexagonal lateral sublattice cannot
be excluded. However, in recent studies using elec-
tron di¡raction [29] that allows detection of the hex-
agonal sublattice next to the orthorhombic one due
to a very small spot size of the beam, no hexagonal
sublattice could be detected in an equimolar CHOL:
CER:FFA mixture. The peaks present at approxi-
mately 0.586 and 0.385 nm and the broad peak be-
tween 11.2 and 14 nm31 indicate phase separation of
CHOL in the presence of FFA.
3.2.2. CER II(1^5)
The di¡raction pattern of lipid mixtures prepared
in the presence of CHOL II(1^5) revealed a similar
phase behaviour as observed in the presence of CER
I(1^5). A hexagonal lateral packing was observed for
Fig. 2. The wide angle X-ray pattern of the CHOL:CER I(1^5)
mixtures in a molar ratio of 0.2:1 (a), 0.4:1 (b) and 1:1 (c) and
the wide angle X-ray pattern of the CHOL:CER I(1^5):FFA in
a molar ratio of 1:1:1 (d). * denotes re£ections based on hy-
drated crystalline cholesterol, h denotes the re£ection character-
istic for the hexagonal phase, and o refers to the re£ections of
the orthorhombic phase. For comparative reasons the curves
are staggered and the intensity is given in arbitrary units.
BBAMEM 77610 6-7-99
J.A. Bouwstra et al. / Biochimica et Biophysica Acta 1419 (1999) 127^136 133
the mixtures prepared from CHOL and CER II(1^5),
while in the presence of FFA an orthorhombic lat-
eral packing was present (not shown).
4. Discussion
Our recent studies in which the lipid organisation
of mixtures prepared from CHOL and CER(1^6) has
been examined revealed that in CHOL:CER(1^6)
mixtures two lamellar phases were present with re-
peat distances of 5.2 and 12.2 nm, respectively, and
that these lipids form a hexagonal lateral packing
[1,29]. The formation of these two lamellar phases
occurred over a CHOL:CER(1^6) molar ratio rang-
ing from 0.4 to 2, indicating a high insensitivity of
these phases toward a change in CHOL content:
only the amount of CHOL that phase separated in-
creased with increasing CHOL:CER(1^6) molar ra-
tio. The ¢nding that only three phases coexist at
room temperature in this multicomponent system is
quite surprising. From our present studies the coex-
isting of di¡erent sublattices cannot be fully ex-
cluded. However this seems to be very unlikely, since
electron di¡raction studies revealed that in equimolar
CHOL:CER and CHOL:CER:FFA mixtures only
one sublattice is present. The insensitivity towards
lipid composition might be of great importance since
in native SC, where depending on the skin source,
the CHOL:CER molar ratio varies between 0.8 and
1.4 (unpublished results). In intact SC not only the
CHOL:CER molar ratio, but also the CER compo-
sition may vary (see Table 3) depending on the skin
source, such as (i) body site, (ii) donor variation and
(iii) skin condition (healthy versus diseased skin).
Therefore, the knowledge on the role of individual
CERs on the lipid organisation may help us to
explain di¡erences observed in the SC barrier func-
tion in vivo. In former studies in which we exam-
ined the phase behaviour of CHOL:CER(1,2) and
CHOL:CER(1^6) mixtures we found that in these
equimolar CHOL:CER mixtures two lamellar phases
were formed. In contrast, in the equimolar
CHOL:CER(2^6) mixture only a very small fraction
of lipids formed the 12^13 nm lamellar phase dem-
onstrating the crucial role of CER 1 for the SC lipid
organisation. Also results of the present study with
equimolar CHOL:CER I(1^5) and CHOL:CER
II(1^5) mixtures support the previous ¢ndings, since
in these mixtures two lamellar phases have been
formed with periodicities of approximately 5.5 nm
and 12.5 nm, respectively. These ¢ndings indicate
Fig. 3. A schematic overview of the lamellar phases of several CHOL:CER mixtures as function of the molar ratio. * data obtained
from [31]. Note the similarity in the lamellar phases of the various CHOL:CER mixtures at an equimolar ratio. The indications weak
(w), medium (m) and strong (s) of the long periodicity phase and CHOL denote the intensities of the re£ections of these phases com-
pared to the intensities of the re£ections attributed to the short periodicity phase.
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that also in the absence of CER 6 two lamellar
phases can be formed. The results of our present
and previous studies (summarised in Fig. 3), indicate
that the lipid organisation of all equimolar
CHOL:CER mixtures tested so far (Table 3) is
very similar. However, exceptional is the weak 12
nm lamellar phase in the CHOL:CER(2^6) mixture.
The results of the previous and present studies sug-
gest that CER 1 plays a distinct role in the organ-
isation of the 12.2 nm phase. In contrast, increasing
the CER 2 content, and decreasing the amounts of
CER 3 and CER 4 does not drastically a¡ect the
lipid organisation. These ¢ndings are in agreement
with the recently proposed molecular model for the
12 nm phase obtained with crystallographic analysis
[16], in which the role of CER 2, CER 3 and CER 4
in the molecular organisation of the 12.2 nm is very
similar. The insensitivity toward a change in CER
composition can be further extended to equimolar
FFA:CHOL:CER mixtures in which also two lamel-
lar phases were formed. This indicates that at an
equimolar ratio a remarkable insensitivity exists to-
ward a change in CER content. When we extend
these ¢ndings to the in vivo situation, in which the
CHOL:CER molar ratio is often close to unity we
can expect that the lipid organisation in native SC
will be insensitive to changes in CER composition
with the only exception when the levels of CER 1
are dramatically reduced. However, in the human
skin the molecular structure of the various CER
slightly di¡ers from that in the pig skin. In human
skin both, CER 1 and CER 4 contain a linoleic acid
linked to the C31/C33 g-hydroxy fatty acid. There-
fore, in human skin the proportion of lipids forming
the 13 nm phase is expected to be reduced when the
relative amounts of both CER 1 and CER 4 are low.
This is in agreement with ¢ndings obtained in a re-
cent study. In this study, in which the relationship
between lipid composition and organisation in native
human SC has been studied, a decrease in the levels
of CER 1 and CER 4 parallels a reduction in the
proportion of lipids that forms the 13 nm phase [30].
By summarising all our ¢ndings (Fig. 3), we can
further conclude that the situation is di¡erent when
the relative CHOL content is reduced. In both
CHOL:CER(1^5) mixtures a gradual change in the
repeat distances is observed when the CHOL content
is decreasing, indicating that the lipid organisation in
the absence of CER 6 is more sensitive toward a
change in CHOL content. In addition, in the
CHOL:CER(1^6) mixtures the 12^13 nm phase is
clearly present already at a molar ratio of 0.2, but
for the formation of the 12^13 nm phase in the
CHOL:CER II(1^5) and CHOL:CER(1,2) mixtures
the CHOL content has to be increased to an 0.4 and
0.6 molar ratio, respectively. Extrapolating these
¢ndings to the in vivo situation in which the long
periodicity phase is thought to be important for the
barrier function. From Fig. 3 we can conclude that
the proportion of lipids that form the long perio-
dicity phase may strongly depend on the overall
CER composition (Fig. 3) only when both the
CHOL:CER molar ratio and the CER composition
change simultaneously. We have to keep in mind that
the SC lipid behaviour will, next to the relative con-
tent of individual SC barrier lipids, also be a¡ected
by their molecular structure, such as the hydrocar-
bon chain lengths of the CER and/or FFA moieties
or the presence of non-saturated FFA. Therefore,
more detailed studies are needed to unravel the
changes in SC lipid composition or structure in dis-
eased skin that lead to barrier abnormalities.
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